+

WO2008014410A3 - Zimlig2 polynucleotides and polypeptides and methods of use - Google Patents

Zimlig2 polynucleotides and polypeptides and methods of use Download PDF

Info

Publication number
WO2008014410A3
WO2008014410A3 PCT/US2007/074509 US2007074509W WO2008014410A3 WO 2008014410 A3 WO2008014410 A3 WO 2008014410A3 US 2007074509 W US2007074509 W US 2007074509W WO 2008014410 A3 WO2008014410 A3 WO 2008014410A3
Authority
WO
WIPO (PCT)
Prior art keywords
zimlig2
polynucleotides
polypeptides
methods
antibodies
Prior art date
Application number
PCT/US2007/074509
Other languages
French (fr)
Other versions
WO2008014410A2 (en
Inventor
Paul O Sheppard
Robert R West
Michael R Stamm
Mark W Appleby
Janine Bilsborough
Penny J Thompson
Kathleen M Walker
Original Assignee
Zymogenetics Inc
Paul O Sheppard
Robert R West
Michael R Stamm
Mark W Appleby
Janine Bilsborough
Penny J Thompson
Kathleen M Walker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc, Paul O Sheppard, Robert R West, Michael R Stamm, Mark W Appleby, Janine Bilsborough, Penny J Thompson, Kathleen M Walker filed Critical Zymogenetics Inc
Publication of WO2008014410A2 publication Critical patent/WO2008014410A2/en
Publication of WO2008014410A3 publication Critical patent/WO2008014410A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Novel Zimlig2 polypeptides, polynucleotides and antibodies have inflammation modulating activity and tumor rejection and killing abilities, and are useful within related research and therapeutic applications.
PCT/US2007/074509 2006-07-26 2007-07-26 Zimlig2 polynucleotides and polypeptides and methods of use WO2008014410A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US82047306P 2006-07-26 2006-07-26
US60/820,473 2006-07-26
US82890306P 2006-10-10 2006-10-10
US60/828,903 2006-10-10
US91397607P 2007-04-25 2007-04-25
US60/913,976 2007-04-25

Publications (2)

Publication Number Publication Date
WO2008014410A2 WO2008014410A2 (en) 2008-01-31
WO2008014410A3 true WO2008014410A3 (en) 2008-05-02

Family

ID=38982353

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/074509 WO2008014410A2 (en) 2006-07-26 2007-07-26 Zimlig2 polynucleotides and polypeptides and methods of use

Country Status (1)

Country Link
WO (1) WO2008014410A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015004248A2 (en) * 2013-07-12 2015-01-15 B.R.A.H.M.S Gmbh Augurin immunoassay

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012708A2 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
WO2003091280A1 (en) * 2002-04-26 2003-11-06 Kirin Beer Kabushiki Kaisha Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012708A2 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
WO2003091280A1 (en) * 2002-04-26 2003-11-06 Kirin Beer Kabushiki Kaisha Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BI M ET AL: "Homo sapiens esophageal cancer related gene 4 protein (ECRG4) mRNA, complete cds", EMBL, 26 December 2000 (2000-12-26), XP002220992 *
SU TAO ET AL: "Cloning and identification of cDNA fragments related to human esophageal cancer", ZHONGHUA ZHONGLIU ZAZHI, vol. 20, no. 4, July 1998 (1998-07-01), pages 254 - 257, XP009096439, ISSN: 0253-3758 *
YUE CHUN-MEI ET AL: "Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma.", WORLD JOURNAL OF GASTROENTEROLOGY : WJG JUN 2003, vol. 9, no. 6, June 2003 (2003-06-01), pages 1174 - 1178, XP002470631, ISSN: 1007-9327 *

Also Published As

Publication number Publication date
WO2008014410A2 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2007143098A3 (en) Hepatocyte growth factor (hgf) binding proteins
WO2007076423A3 (en) INHIBITORS OF Akt ACTIVITY
WO2008098104A8 (en) Inhibitors of akt activity
WO2007007173A3 (en) Human anti-madcam antibodies
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
WO2008085987A3 (en) Drug delivery to human tissues by single chain variable region antibody fragments cloned by phage display
WO2004092215A3 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
WO2008065378A3 (en) Binding members for interleukin-6
NZ598524A (en) Therapeutic dll4 binding proteins
WO2005074546A3 (en) Modified human growth hormone polypeptides and their uses
PL1976886T3 (en) Means and methods for the treatment of tumorous diseases
EP3281956A3 (en) Human antibody drug conjugates against tissue factor
MY154904A (en) Neuropilin antagonists
EP2068925A4 (en) Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
WO2007044534A3 (en) Vegf analogs and methods of use
WO2009013543A3 (en) Targeted binging agents directed to kdr and uses thereof - 035
WO2010100056A3 (en) Antibodies against a proliferating inducing ligand (april)
EA200701448A1 (en) SPECIFICALLY CONNECTED TO OUR MOBILE COURSE.
WO2007019865A3 (en) Therapy with cd4 binding peptides and radiation
WO2007011639A3 (en) Catalytic immunoglobulins
WO2006109044A3 (en) Selective modulation of tumour necrosis factor receptors in therapy
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
WO2009009587A3 (en) Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07813431

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07813431

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载